Personal tools

DOID:4236: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{DOID
{{DOID
|id=DOID:4236
|alt_id=DOID:1971;;DOID:2610;;DOID:4234
|name=carcinosarcoma
|namespace=disease_ontology
|def="MERGED DEFINITION:\nTARGET DEFINITION: A mixed cell type cancer that has_material_basis_in carcinomatous (epithelial tissue) and sarcomatous (connective tissue) components.\n--------------------\nSOURCE DEFINITION: A mullerian mixed tumor that is composed_of carcinoma of different mﾃｼllerian types and composed_of homologous or heterologous sarcoma-like components." [url:http\://en.wikipedia.org/wiki/Mixed_M%C3%BCllerian_tumor, url:http\://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=44003&version=Patient&language=English, url:http\://www.cancer.gov/dictionary/?CdrID=44003]
|xref=MSH:D002296;;NCI:C34448;;SNOMEDCT_2010_1_31:112684005;;SNOMEDCT_2010_1_31:189808004;;SNOMEDCT_2010_1_31:63264007;;SNOMEDCT_2010_1_31:84427001;;UMLS_CUI:C0007140;;UMLS_CUI:C0206626;;UMLS_CUI:C0206627;;UMLS_CUI:C1334603
|is_a=DOID:154
|synonym="carcinosarcoma" EXACT [CSP2005:2000-3358];;"carcinosarcoma" EXACT [NCI2004_11_17:C34448];;"Carcinosarcoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63264007];;"Carcinosarcoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189808004];;"malignant mixed mesodermal (mullerian) tumor" EXACT [];;"malignant mixed Mullerian tumor" EXACT [];;"mesodermal mixed tumor" EXACT [];;"Mesodermal mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:112684005];;"mixed Mesodermal (mullerian) tumor" EXACT [NCI2004_11_17:C3730];;"MMMT" EXACT [NCI2004_11_17:C8975];;"mullerian mixed tumor" EXACT [];;"mullerian mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:84427001]
|comment=
|comment=
|alt_id=DOID:1971;;DOID:2610;;DOID:4234
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def="MERGED DEFINITION:\nTARGET DEFINITION: A mixed cell type cancer that has_material_basis_in carcinomatous (epithelial tissue) and sarcomatous (connective tissue) components.\n--------------------\nSOURCE DEFINITION: A mullerian mixed tumor that is composed_of carcinoma of different m��ｽｼllerian types and composed_of homologous or heterologous sarcoma-like components." [url:http://en.wikipedia.org/wiki/Mixed_M%C3%BCllerian_tumor, url:http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id
|subset=
|adjacent_to=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=DOID:4236
|is_a=DOID:154
|is_obsolete=
|located_in=
|located_in=
|name=carcinosarcoma
|namespace=FANTOM
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
|subset=
|preceded_by=
|synonym="carcinosarcoma" EXACT [CSP2005:2000-3358];;"carcinosarcoma" EXACT [NCI2004_11_17:C34448];;"Carcinosarcoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63264007];;"Carcinosarcoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189808004];;"malignant mixed mesodermal (mullerian) tumor" EXACT [];;"malignant mixed Mullerian tumor" EXACT [];;"mesodermal mixed tumor" EXACT [];;"Mesodermal mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:112684005];;"mixed Mesodermal (mullerian) tumor" EXACT [NCI2004_11_17:C3730];;"MMMT" EXACT [NCI2004_11_17:C8975];;"mullerian mixed tumor" EXACT [];;"mullerian mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:84427001]
|union_of=
|xref=MSH:D002296;;NCI:C34448;;SNOMEDCT_2010_1_31:112684005;;SNOMEDCT_2010_1_31:189808004;;SNOMEDCT_2010_1_31:63264007;;SNOMEDCT_2010_1_31:84427001;;UMLS_CUI:C0007140;;UMLS_CUI:C0206626;;UMLS_CUI:C0206627;;UMLS_CUI:C1334603
}}
}}

Latest revision as of 16:51, 12 September 2014

Name:carcinosarcoma
Namespace:FANTOM
Definition:"MERGED DEFINITION:\nTARGET DEFINITION: A mixed cell type cancer that has_material_basis_in carcinomatous (epithelial tissue) and sarcomatous (connective tissue) components.\n--------------------\nSOURCE DEFINITION: A mullerian mixed tumor that is composed_of carcinoma of different m��ｽｼllerian types and composed_of homologous or heterologous sarcoma-like components." [url:http://en.wikipedia.org/wiki/Mixed_M%C3%BCllerian_tumor, url:http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id
Xrefs:
links:

MSH:D002296
NCI:C34448
SNOMEDCT_2010_1_31:112684005
SNOMEDCT_2010_1_31:189808004
SNOMEDCT_2010_1_31:63264007
SNOMEDCT_2010_1_31:84427001
UMLS_CUI:C0007140
UMLS_CUI:C0206626
UMLS_CUI:C0206627

UMLS_CUI:C1334603
Synonyms: "carcinosarcoma" EXACT [CSP2005:2000-3358]
"carcinosarcoma" EXACT [NCI2004_11_17:C34448]
"Carcinosarcoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63264007]
"Carcinosarcoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189808004]
"malignant mixed mesodermal (mullerian) tumor" EXACT []
"malignant mixed Mullerian tumor" EXACT []
"mesodermal mixed tumor" EXACT []
"Mesodermal mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:112684005]
"mixed Mesodermal (mullerian) tumor" EXACT [NCI2004_11_17:C3730]
"MMMT" EXACT [NCI2004_11_17:C8975]
"mullerian mixed tumor" EXACT []
"mullerian mixed tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:84427001]
Alt_id: DOID:1971
DOID:2610
DOID:4234

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data

Parents

is_a:DOID:154(mixed cell type cancer)



Children


is a:FF:10689-109F5 (mixed mullerian tumor cell line:HTMMT)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

Mouse (Mus musculus)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:4236 (carcinosarcoma), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

P-valueFFCPShort description
1.55e-98FFCP PHASE2:Hg19::chr18:63096932..63096933,+#_6c1e344cd6bb46d417df045082a5f56ep@chr18:63096932..63096933, +
1.55e-98FFCP PHASE1:Hg19::chr18:63096932..63096933,+#_6c1e344cd6bb46d417df045082a5f56ep@chr18:63096932..63096933, +
1.55e-98FFCP PHASE2:Hg19::chr7:146741072..146741077,+#_6c1e344cd6bb46d417df045082a5f56ep@chr7:146741072..146741077, +
1.55e-98FFCP PHASE1:Hg19::chr7:146741072..146741077,+#_6c1e344cd6bb46d417df045082a5f56ep@chr7:146741072..146741077, +
4.52e-50FFCP PHASE2:Hg19::chr2:156009264..156009270,-#_962df8d5bf8792bf70c81010560cb32bp@chr2:156009264..156009270, -
4.52e-50FFCP PHASE1:Hg19::chr2:156009264..156009270,-#_962df8d5bf8792bf70c81010560cb32bp@chr2:156009264..156009270, -
4.52e-50FFCP PHASE2:Hg19::chr6:5999833..5999837,-#_962df8d5bf8792bf70c81010560cb32bp@chr6:5999833..5999837, -
4.52e-50FFCP PHASE1:Hg19::chr6:5999833..5999837,-#_962df8d5bf8792bf70c81010560cb32bp@chr6:5999833..5999837, -
4.52e-50FFCP PHASE2:Hg19::chrX:31582142..31582159,+#_962df8d5bf8792bf70c81010560cb32bp@chrX:31582142..31582159, +
4.52e-50FFCP PHASE1:Hg19::chrX:31582142..31582159,+#_962df8d5bf8792bf70c81010560cb32bp@chrX:31582142..31582159, +
1.22e-44FFCP PHASE1:Hg19::chr13:37575605..37575619,+#_54ef26746974fe775dc87bb71a94a397p4@EXOSC8
1.22e-44FFCP PHASE2:Hg19::chr13:37575605..37575619,+#_54ef26746974fe775dc87bb71a94a397p4@EXOSC8
5.99e-41FFCP PHASE1:Hg19::chr12:57619653..57619657,+#_8a6ffcd28339141c5d1213150a3dec09p3@NXPH4
5.99e-41FFCP PHASE2:Hg19::chr12:57619653..57619657,+#_8a6ffcd28339141c5d1213150a3dec09p3@NXPH4
3.61e-34FFCP PHASE2:Hg19::chr18:63091237..63091256,+#_4d18b458f08a437b1ab612510630ad8bp@chr18:63091237..63091256, +
3.61e-34FFCP PHASE1:Hg19::chr18:63091237..63091256,+#_4d18b458f08a437b1ab612510630ad8bp@chr18:63091237..63091256, +
3.61e-34FFCP PHASE2:Hg19::chr9:22141969..22141972,+#_4d18b458f08a437b1ab612510630ad8bp@chr9:22141969..22141972, +
3.61e-34FFCP PHASE1:Hg19::chr9:22141969..22141972,+#_4d18b458f08a437b1ab612510630ad8bp@chr9:22141969..22141972, +
5.04e-34FFCP PHASE1:Hg19::chr12:57882498..57882504,-#_4b0aa5e837624e1fb4e6a4aa0315f17cp39@ARHGAP9
5.04e-34FFCP PHASE2:Hg19::chr6:144724124..144724133,+#_4b0aa5e837624e1fb4e6a4aa0315f17cp@chr6:144724124..144724133, +
5.04e-34FFCP PHASE1:Hg19::chr6:144724124..144724133,+#_4b0aa5e837624e1fb4e6a4aa0315f17cp@chr6:144724124..144724133, +
5.04e-34FFCP PHASE2:Hg19::chr4:80976547..80976566,-#_4b0aa5e837624e1fb4e6a4aa0315f17cp30@ANTXR2
5.04e-34FFCP PHASE1:Hg19::chr4:80976547..80976566,-#_4b0aa5e837624e1fb4e6a4aa0315f17cp30@ANTXR2
5.04e-34FFCP PHASE2:Hg19::chr12:57882498..57882504,-#_4b0aa5e837624e1fb4e6a4aa0315f17cp39@ARHGAP9
7.05e-34FFCP PHASE2:Hg19::chr2:38466814..38466823,-#_6a9e0911496cdc451ebef871142d004ep8@ENST00000450854
7.05e-34FFCP PHASE1:Hg19::chr2:38466814..38466823,-#_6a9e0911496cdc451ebef871142d004ep8@ENST00000450854
7.05e-34FFCP PHASE1:Hg19::chr15:32969649..32969656,+#_6a9e0911496cdc451ebef871142d004ep14@SCG5
7.05e-34FFCP PHASE2:Hg19::chr6:33145331..33145378,-#_6a9e0911496cdc451ebef871142d004ep@chr6:33145331..33145378, -
7.05e-34FFCP PHASE1:Hg19::chr6:33145331..33145378,-#_6a9e0911496cdc451ebef871142d004ep@chr6:33145331..33145378, -
7.05e-34FFCP PHASE2:Hg19::chr15:32969649..32969656,+#_6a9e0911496cdc451ebef871142d004ep14@SCG5
7.05e-34FFCP PHASE1:Hg19::chr15:75114185..75114190,+#_6a9e0911496cdc451ebef871142d004ep@chr15:75114185..75114190, +
7.05e-34FFCP PHASE2:Hg19::chr15:75114185..75114190,+#_6a9e0911496cdc451ebef871142d004ep@chr15:75114185..75114190, +
8.05e-30FFCP PHASE1:Hg19::chr12:57619841..57619852,+#_f878dae837075addd6a6b2c8818e8f9ep@chr12:57619841..57619852, +
8.05e-30FFCP PHASE2:Hg19::chr12:57619841..57619852,+#_f878dae837075addd6a6b2c8818e8f9ep@chr12:57619841..57619852, +
4.08e-26FFCP PHASE2:Hg19::chr16:56380852..56380864,+#_aebfe94998ceac330b6f65855fc81b36p@chr16:56380852..56380864, +
4.08e-26FFCP PHASE1:Hg19::chr16:56380852..56380864,+#_aebfe94998ceac330b6f65855fc81b36p@chr16:56380852..56380864, +
4.32e-26FFCP PHASE2:Hg19::chr6:27198345..27198350,-#_3cbe8548999c28350db5291158d69133p@chr6:27198345..27198350, -
4.32e-26FFCP PHASE1:Hg19::chr6:27198345..27198350,-#_3cbe8548999c28350db5291158d69133p@chr6:27198345..27198350, -
5.56e-26FFCP PHASE2:Hg19::chr2:187615989..187616000,+#_23e3bfa9120fd2352f08f3896a5dfd4cp@chr2:187615989..187616000, +
5.56e-26FFCP PHASE2:Hg19::chr7:81635124..81635130,-#_23e3bfa9120fd2352f08f3896a5dfd4cp18@CACNA2D1
5.56e-26FFCP PHASE1:Hg19::chr2:187615989..187616000,+#_23e3bfa9120fd2352f08f3896a5dfd4cp@chr2:187615989..187616000, +
5.56e-26FFCP PHASE1:Hg19::chr7:81635124..81635130,-#_23e3bfa9120fd2352f08f3896a5dfd4cp18@CACNA2D1
5.56e-26FFCP PHASE1:Hg19::chr11:22359292..22359301,+#_23e3bfa9120fd2352f08f3896a5dfd4cp9@SLC17A6
5.56e-26FFCP PHASE2:Hg19::chr11:22359292..22359301,+#_23e3bfa9120fd2352f08f3896a5dfd4cp9@SLC17A6
7.14e-26FFCP PHASE2:Hg19::chrX:89176902..89176913,+#_7b69406b9ccebe82b0a5f274c7e1b864p1@TGIF2LX
7.14e-26FFCP PHASE1:Hg19::chrX:89176902..89176913,+#_7b69406b9ccebe82b0a5f274c7e1b864p1@TGIF2LX
7.14e-26FFCP PHASE2:Hg19::chr2:187618737..187618746,+#_7b69406b9ccebe82b0a5f274c7e1b864p@chr2:187618737..187618746, +
7.14e-26FFCP PHASE1:Hg19::chr2:187618737..187618746,+#_7b69406b9ccebe82b0a5f274c7e1b864p@chr2:187618737..187618746, +
9.18e-26FFCP PHASE2:Hg19::chr3:170424675..170424679,-#_0a3a08778c62ccd8ce38dcaf03637175p@chr3:170424675..170424679, -
9.18e-26FFCP PHASE1:Hg19::chr3:170424675..170424679,-#_0a3a08778c62ccd8ce38dcaf03637175p@chr3:170424675..170424679, -
9.18e-26FFCP PHASE2:Hg19::chr12:15202725..15202774,+#_0a3a08778c62ccd8ce38dcaf03637175p@chr12:15202725..15202774, +
9.18e-26FFCP PHASE2:Hg19::chr9:16515712..16515717,-#_0a3a08778c62ccd8ce38dcaf03637175p@chr9:16515712..16515717, -
9.18e-26FFCP PHASE2:Hg19::chr3:165528391..165528411,+#_0a3a08778c62ccd8ce38dcaf03637175p@chr3:165528391..165528411, +
9.18e-26FFCP PHASE1:Hg19::chr9:16515712..16515717,-#_0a3a08778c62ccd8ce38dcaf03637175p@chr9:16515712..16515717, -
9.18e-26FFCP PHASE1:Hg19::chr3:165528391..165528411,+#_0a3a08778c62ccd8ce38dcaf03637175p@chr3:165528391..165528411, +
9.18e-26FFCP PHASE1:Hg19::chr12:15202725..15202774,+#_0a3a08778c62ccd8ce38dcaf03637175p@chr12:15202725..15202774, +
3.91e-23FFCP PHASE2:Hg19::chr14:20813564..20813582,+#_169af5b68d6647ba1387eb9c1069011ep@chr14:20813564..20813582, +
3.91e-23FFCP PHASE1:Hg19::chr14:20813564..20813582,+#_169af5b68d6647ba1387eb9c1069011ep@chr14:20813564..20813582, +
5.41e-22FFCP PHASE2:Hg19::chr5:180708225..180708231,-#_0053e1b2daffc28f1c6ce2a356ae0ec4p@chr5:180708225..180708231, -
5.41e-22FFCP PHASE1:Hg19::chr5:180708225..180708231,-#_0053e1b2daffc28f1c6ce2a356ae0ec4p@chr5:180708225..180708231, -
3.11e-21FFCP PHASE2:Hg19::chr7:146244949..146244953,+#_61fb641f8518c865fda9b37c2e180f59p@chr7:146244949..146244953, +
3.11e-21FFCP PHASE1:Hg19::chr7:146244949..146244953,+#_61fb641f8518c865fda9b37c2e180f59p@chr7:146244949..146244953, +
3.81e-21FFCP PHASE2:Hg19::chr6:144724186..144724199,+#_e949d0c02080d2abdecc238067c81033p@chr6:144724186..144724199, +
3.81e-21FFCP PHASE1:Hg19::chr6:144724186..144724199,+#_e949d0c02080d2abdecc238067c81033p@chr6:144724186..144724199, +
4.66e-21FFCP PHASE2:Hg19::chr4:80976472..80976514,-#_fe9310adcec7ab98726d49d0538f874dp33@ANTXR2
4.66e-21FFCP PHASE1:Hg19::chr4:80976472..80976514,-#_fe9310adcec7ab98726d49d0538f874dp33@ANTXR2
4.66e-21FFCP PHASE2:Hg19::chr6:83938642..83938649,-#_fe9310adcec7ab98726d49d0538f874dp7@ME1
4.66e-21FFCP PHASE1:Hg19::chr6:83938642..83938649,-#_fe9310adcec7ab98726d49d0538f874dp7@ME1
4.66e-21FFCP PHASE2:Hg19::chr17:70026911..70026922,+#_fe9310adcec7ab98726d49d0538f874dp1@uc002jit.1
4.66e-21FFCP PHASE1:Hg19::chr17:70026911..70026922,+#_fe9310adcec7ab98726d49d0538f874dp1@uc002jit.1
5.2e-21FFCP PHASE2:Hg19::chr4:19458597..19458623,-#_168ef642b5ab671a089969edf02c375dp1@ENST00000505347
5.2e-21FFCP PHASE1:Hg19::chr4:19458597..19458623,-#_168ef642b5ab671a089969edf02c375dp1@ENST00000505347
5.7e-21FFCP PHASE2:Hg19::chr9:22216803..22216809,-#_c02a8fde2fb04929678760baf214a104p@chr9:22216803..22216809, -
5.7e-21FFCP PHASE1:Hg19::chr9:22216803..22216809,-#_c02a8fde2fb04929678760baf214a104p@chr9:22216803..22216809, -
5.7e-21FFCP PHASE1:Hg19::chr11:811679..811684,+#_c02a8fde2fb04929678760baf214a104p2@SNORA52
5.7e-21FFCP PHASE2:Hg19::chr11:811679..811684,+#_c02a8fde2fb04929678760baf214a104p2@SNORA52
5.7e-21FFCP PHASE2:Hg19::chr4:80116986..80116991,+#_c02a8fde2fb04929678760baf214a104p1@ENST00000507476, p1@ENST00000507761, p1@ENST00000515597, p1@uc003hls.2
5.7e-21FFCP PHASE1:Hg19::chr4:80116986..80116991,+#_c02a8fde2fb04929678760baf214a104p1@ENST00000507476, p1@ENST00000507761, p1@ENST00000515597, p1@uc003hls.2
5.7e-21FFCP PHASE2:Hg19::chr2:118145500..118145514,-#_c02a8fde2fb04929678760baf214a104p@chr2:118145500..118145514, -
5.7e-21FFCP PHASE2:Hg19::chr1:149875845..149875874,-#_c02a8fde2fb04929678760baf214a104p@chr1:149875845..149875874, -
5.7e-21FFCP PHASE1:Hg19::chr2:118145500..118145514,-#_c02a8fde2fb04929678760baf214a104p@chr2:118145500..118145514, -
5.7e-21FFCP PHASE1:Hg19::chr1:149875845..149875874,-#_c02a8fde2fb04929678760baf214a104p@chr1:149875845..149875874, -
6.96e-21FFCP PHASE2:Hg19::chr3:47088671..47088676,-#_47da884348796f1285647e8fe3ce18dbp28@SETD2
6.96e-21FFCP PHASE1:Hg19::chr15:75114132..75114162,+#_47da884348796f1285647e8fe3ce18dbp@chr15:75114132..75114162, +
6.96e-21FFCP PHASE1:Hg19::chr3:47088671..47088676,-#_47da884348796f1285647e8fe3ce18dbp28@SETD2
6.96e-21FFCP PHASE2:Hg19::chr2:182543992..182543996,-#_47da884348796f1285647e8fe3ce18dbp10@NEUROD1
6.96e-21FFCP PHASE1:Hg19::chr2:182543992..182543996,-#_47da884348796f1285647e8fe3ce18dbp10@NEUROD1
6.96e-21FFCP PHASE2:Hg19::chr2:70900377..70900392,+#_47da884348796f1285647e8fe3ce18dbp@chr2:70900377..70900392, +
6.96e-21FFCP PHASE2:Hg19::chr15:75114132..75114162,+#_47da884348796f1285647e8fe3ce18dbp@chr15:75114132..75114162, +
6.96e-21FFCP PHASE1:Hg19::chr2:70900377..70900392,+#_47da884348796f1285647e8fe3ce18dbp@chr2:70900377..70900392, +
9.6e-20FFCP PHASE2:Hg19::chr11:31832207..31832226,-#_a2768554b78748a57d842b539237440fp12@PAX6
9.6e-20FFCP PHASE1:Hg19::chr11:31832207..31832226,-#_a2768554b78748a57d842b539237440fp12@PAX6
5.48e-18FFCP PHASE2:Hg19::chr7:146192665..146192668,+#_1f505841d5a5733da262087c031b7ca2p@chr7:146192665..146192668, +
5.48e-18FFCP PHASE1:Hg19::chr7:146192665..146192668,+#_1f505841d5a5733da262087c031b7ca2p@chr7:146192665..146192668, +
5.48e-18FFCP PHASE2:Hg19::chr6:27198375..27198387,-#_1f505841d5a5733da262087c031b7ca2p@chr6:27198375..27198387, -
5.48e-18FFCP PHASE1:Hg19::chr6:27198375..27198387,-#_1f505841d5a5733da262087c031b7ca2p@chr6:27198375..27198387, -
6.48e-18FFCP PHASE2:Hg19::chr7:54614335..54614351,+#_82ae5dc1c4f2791fdbb24f0ec175b5f0p19@VSTM2A
6.48e-18FFCP PHASE1:Hg19::chr7:54614335..54614351,+#_82ae5dc1c4f2791fdbb24f0ec175b5f0p19@VSTM2A
7.67e-18FFCP PHASE2:Hg19::chr6:150016353..150016358,-#_fba23060a943b4391ed559e4bd4437eap@chr6:150016353..150016358, -
7.67e-18FFCP PHASE2:Hg19::chr4:120243571..120243587,-#_fba23060a943b4391ed559e4bd4437eap3@FABP2

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=DOID:4236&oldid=3275706"